Amgen, Abbott Win BayBio Awards
Amgen (NASDAQ: AMGN) and Abbott Laboratories (NYSE: ABT) took home a couple of the top prizes last night at the BayBio Pantheon Awards. Amgen received honors for the best therapeutic with denosumab (Prolia) for osteoporosis, while Abbott won for the outstanding medical device—a product called MitraClip that repairs leaky heart valves without requiring surgery, which it acquired from Menlo Park, CA-based Evalve. Other winners included Solazyme, the South San Francisco-based developer of biofuels; Pacific Biosciences, the DNA sequencing toolmaker in Menlo Park, CA; and Emeryville, CA-based cancer drug developer Onyx Pharmaceuticals (NASDAQ: ONXX), among others. The event drew a record-high 700 attendees, according to BayBio. For a complete list of the winners, click here.